Gazyva 1000 mg/40 mL injection for intravenous infusion Images
Generic Name: obinutuzumab
This medication has been identified as Gazyva 1000 mg/40 mL injection for intravenous infusion. It is supplied by Genentech, Inc.
Gazyva is used in the treatment of Chronic Lymphocytic Leukemia; Follicular Lymphoma and belongs to the drug class CD20 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Gazyva 1000 mg/40 mL injection for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Gazyva
- Generic Name
- obinutuzumab
- Strength
- 1000 mg/40 mL injection for intravenous infusion
- Availability
- Prescription only
- Drug Class
- CD20 monoclonal antibodies
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0070
More about Gazyva (obinutuzumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.